Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSL | P07711 | 1/20 | 0.63 |
| ▸ | FURIN | P09958 | 13/20 | 0.58 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.58 |
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.57 |
| ▸ | PCSK6 | P29122 | 1/20 | 0.53 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.49 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.49 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.49 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.49 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.49 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.49 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.49 |
| ▸ | ROCK2 | O75116 | 2/20 | 0.48 |
| ▸ | PRKACA | P17612 | 1/20 | 0.46 |
| ▸ | AKT3 | Q9Y243 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5604836 | 0.87 | SLC6A5 (0.65) | CTSLFURINSLC6A5 | |
| SCHEMBL31130725 | 0.86 | NPY4R (0.53) | CTSLFURINPRSS1SLC6A5 | |
| SCHEMBL30496941 | 0.84 | SLC6A5 (0.69) | CTSLSLC6A5 | |
| SCHEMBL29640398 | 0.84 | SLC6A5 (0.69) | CTSLSLC6A5 | |
| SCHEMBL30496951 | 0.84 | SLC6A5 (0.69) | CTSLSLC6A5 | |
| SCHEMBL29640374 | 0.84 | SLC6A5 (0.69) | CTSLSLC6A5 | |
| SCHEMBL15363905 | 0.84 | SLC6A5 (0.69) | CTSLSLC6A5 | |
| SCHEMBL5955042 | 0.83 | SLC6A5 (0.64) | CTSLFURINPRSS1SLC6A5 | |
| SCHEMBL352420 | 0.83 | SLC6A5 (0.58) | CTSLSLC6A5 | |
| SCHEMBL1673194 | 0.83 | SLC6A5 (0.58) | CTSLSLC6A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240389587-A1 | COMPOSITIONS AND METHODS FOR CONTROLLING PHYTOPATHOGENIC INFECTIONS | INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE, L'ALIMENTATION ET L'ENVIRONNEMENT (INRAE) (FR) | 2024-11-28 | — | — | US | disclosed |
| EP-4440313-A1 | COMPOSITIONS AND METHODS FOR CONTROLLING PHYTOPATHOGENIC INFECTIONS | Institut national de recherche pour l'agriculture, L'alimentation et l'environnement (INRAE) (FR) | 2024-10-09 | — | — | EP | disclosed |
| WO-2023099609-A1 | COMPOSITIONS AND METHODS FOR CONTROLLING PHYTOPATHOGENIC INFECTIONS | INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE, L'ALIMENTATION ET L'ENVIRONNEMENT (INRAE) (FR) | 2023-06-08 | — | — | WO | disclosed |
| EP-4186367-A1 | COMPOSITIONS AND METHODS FOR CONTROLLING PHYTOPATHOGENIC INFECTIONS | Institut national de recherche pour l'agriculture, l'alimentation et l'environnement (INRAE) (FR) | 2023-05-31 | — | — | EP | disclosed |
| US-11566260-B2 | Potentiating agents for protecting plants from fungal infections | UNIVERSITE D'ANGERS (FR) | 2023-01-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11566260-B2 | Potentiating agents for protecting plants from fungal infections | ERG28, GUSB, CTSA | CTSL 1427/4885FURIN 3268/4885PRSS1 2227/4885 |
| US-20240389587-A1 | COMPOSITIONS AND METHODS FOR CONTROLLING PHYTOPATHOGENIC INFECTIONS | XBP1, ERN1, ERN2 | CTSL 3242/4885FURIN 2449/4885PRSS1 448/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.